Trials / Completed
CompletedNCT00407433
Clinical Studies of Gemcitabine-Oxaliplatin
Phase 2 Single-Arm Studies of Gemcitabine in Combination With Oxaliplatin Refractory and Relapsed Pediatric Solid Tumors
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 156 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 6 Months – 20 Years
- Healthy volunteers
- Not accepted
Summary
These are Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory or relapsing pediatric solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Gemcitabine (Gemzar®), Oxaliplatin (Eloxatin®) |
Timeline
- First posted
- 2006-12-05
- Last updated
- 2009-08-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00407433. Inclusion in this directory is not an endorsement.